Profound Medical (PROF) Income Statement
Profound Medical Income Statement
Last quarter (Q2 2026), Profound Medical's total revenue was $2.42M, an increase of 9.40% from the same quarter last year. In Q2, Profound Medical's net income was $-9.29M. See Profound Medical’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 16.38M | $ 10.68M | $ 7.20M | $ 6.68M | $ 6.87M | |
| $ 11.59M | $ 7.04M | $ 4.38M | $ 3.02M | $ 2.95M | |
| $ 53.57M | $ 40.10M | $ 33.00M | $ 32.62M | $ 33.24M | |
| Depreciation and Amortization | $ 569.80K | $ 936.00K | $ 929.00K | $ 1.60M | $ 1.88M |
| $ -41.41M | $ -32.13M | $ -27.00M | $ -26.60M | $ -28.65M | |
| $ -41.98M | $ -33.06M | $ -28.62M | $ -32.13M | $ -30.29M | |
| $ -1.08M | $ 5.24M | $ 200.00K | $ 3.74M | $ -303.00K | |
| $ -43.06M | $ -27.82M | $ -28.45M | $ -28.38M | $ -30.59M | |
| $ -43.32M | $ -27.82M | $ -28.57M | $ -28.67M | $ -30.70M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.43 | $ -1.12 | $ -1.35 | $ -1.38 | $ -1.50 |
| Diluted EPS | $ -1.43 | $ -1.12 | $ -1.35 | $ -1.38 | $ -1.50 |
| Weighted Average Shares Outstanding | 30.23M | 24.77M | 21.18M | 20.77M | 20.46M |
| Weighted Average Shares Outstanding (Diluted) | 30.23M | 24.77M | 21.18M | 20.77M | 20.47M |
Currency in CAD
